ZSX Medical LLC
Internal suturing for OB/GYN and other surgeries
This article was originally published in Start Up
Executive Summary
Internal surgical closure following hysterectomies and C-sections is time-consuming, and it is associated with a number of costly complications, including infection and gynecologic adhesions. Reducing complications for patients and the resulting cost burden to health care systems worldwide are the goals of ZSX Medical LLC, which has developed a laparoscopic, bioabsorbable internal surgical closure system designed to be a superior alternative to standard suturing and stapling technologies used in hysterectomies, C-sections and other OB/GYN surgeries.
You may also be interested in...
Surgical Incision Closure: Start-Ups Address A Megatrend In Health Care
Medtech start-ups are working to develop next-generation incision closure devices that address the shortfalls of gold standard sutures and staples. We profile three hopefuls in this issue: EndoEvolution, ZipLine Medical and ZSX Medical.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.